Kraig Biocraft Laboratories Provides Production Update on Recombinant Spider Silk Operations

Core Insights - Kraig Biocraft Laboratories, Inc. is advancing its recombinant spider silk production, currently in the largest batch to date [1] - The first half of the current production batch has been completed, with the second half expected to finish in the next 14 days [2] - This production run marks a significant milestone with the first simultaneous batches of BAM-1 produced in new facilities, demonstrating the scalability and reliability of the production model [3] Production Progress - The company has successfully completed the production of all BAM-1 hybrid eggs for release over the next month, ensuring a steady supply for future production cycles [4] - The execution of simultaneous production batches showcases the scalability of the technology from batch processing to continuous flow manufacturing [5] Strategic Positioning - The company is positioned to accelerate the growth and commercialization of its eco-friendly and high-performance spider silk fibers, with ongoing updates expected as production and commercialization goals progress [5] - Kraig Labs is recognized as a leading developer of genetically engineered spider silk-based fiber technologies, with significant implications for the global textile industry [7]